Ziresovir Reduces Signs, Symptoms of Bronchiolitis in Babies With …
WEB1 day ago — At day 5, the reduction in the RSV viral load was greater in the ziresovir group than the placebo group (−2.5 versus −1.9 log 10 copies/mL). Prespecified subgroups, including those with a ...
Only 56% of US infants protected by RSV vaccine, antibody
WEB1 day ago — Infant coverage with nirsevimab was 44.6%. Again, use was higher among those who received a provider recommendation for either maternal or infant RSV immunization (58.7%) comparedwith those who did not receive a recommendation (28.3%). Overall, 55.8% of infants were protected by either maternal RSV vaccination, nirsevimab, or both; 14.2% of ...
Ziresovir Reduces Bronchiolitis in Infants Hospitalized With RSV
WEB4 days ago — The trial's findings demonstrate that ziresovir significantly improved clinical outcomes in infants and young children hospitalized with RSV. In the intention-to-treat population of 244 ...
Ziresovir reduces signs, symptoms of bronchiolitis in babies with RSV
WEB4 days ago — by Elana Gotkine. For infants and young children hospitalized with respiratory syncytial virus (RSV) infection, ziresovir reduces signs and symptoms of bronchiolitis, according to a study ...
Ziresovir Reduces Signs, Symptoms of Bronchiolitis in Babies With …
WEB4 days ago — FRIDAY, Sept. 27, 2024 -- For infants and young children hospitalized with respiratory syncytial virus (RSV) infection, ziresovir reduces signs and symptoms of bronchiolitis, according to a study published in the Sept. 26 issue of the New England Journal of Medicine.
Ziresovir in Hospitalized Infants with Respiratory Syncytial Virus ...
WEB6 days ago — Respiratory syncytial virus (RSV) is a leading cause of severe illness in infants, with no effective treatment. Results of a phase 2 trial suggested that ziresovir may have efficacy in the...
Ziresovir Eases Bronchiolitis, Is Safe For Children Two Years And ...
WEB5 days ago — MedPage Today (9/25, Kahn) reports, “An investigational oral antiviral drug eased bronchiolitis and was safe for children 2 years and younger hospitalized with respiratory syncytial virus (RSV) infection, according to a phase III trial in China.”
Ziresovir in Hospitalized Infants with RSV Infection
WEBZiresovir in Hospitalized Infants with RSV Infection. No respiratory syncytial virus vaccines are approved for children, and the only available treatment, aerosolized ribavirin, has …
WEB6 days ago — Ziresovir treatment reduced signs and symptoms of bronchiolitis in infants and young children hospitalized with RSV infection. No safety concerns were identified.
'Encouraging': Antiviral ziresovir shows promise against RSV
WEB5 days ago — The investigational antiviral ziresovir showed promise for the treatment of respiratory syncytial virus infection in infants during a phase 3 trial in China, researchers reported in The New ...
- Some results have been removed